Cargando…

VAV2: a novel prognostic marker and a druggable target for adrenocortical carcinoma

Detalles Bibliográficos
Autores principales:	Ruggiero, Carmen, Lalli, Enzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687602/ https://www.ncbi.nlm.nih.gov/pubmed/29179432 http://dx.doi.org/10.18632/oncotarget.21448

Ejemplares similares

Establishment of a mouse xenograft model of metastatic adrenocortical carcinoma
por: Morin, Aurélie, et al.
Publicado: (2017)

Steroidogenic Factor 1, a Goldilocks Transcription Factor from Adrenocortical Organogenesis to Malignancy
por: Relav, Lauriane, et al.
Publicado: (2023)

Evaluation of Vav3.1 as prognostic marker in endometrial cancer
por: Boesch, Maximilian, et al.
Publicado: (2018)

Adrenocortical Carcinoma
por: Berruti, Alfredo, et al.
Publicado: (2021)

Astemizole Sensitizes Adrenocortical Carcinoma Cells to Doxorubicin by Inhibiting Patched Drug Efflux Activity
por: Hasanovic, Anida, et al.
Publicado: (2020)

Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma
por: Siebert, Claudia, et al.
Publicado: (2019)

The Tumor Microenvironment: A Druggable Target for Metastatic Disease?
por: EBioMedicine
Publicado: (2018)

Pediatric Adrenocortical Tumors: What They Can Tell Us on Adrenal Development and Comparison with Adult Adrenal Tumors
por: Lalli, Enzo, et al.
Publicado: (2015)

FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
por: Kim, Jieun, et al.
Publicado: (2023)

Impact of ACTH Signaling on Transcriptional Regulation of Steroidogenic Genes
por: Ruggiero, Carmen, et al.
Publicado: (2016)

Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma
por: Jouinot, Anne, et al.
Publicado: (2020)

Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma
por: Lacombe, Amanda Meneses Ferreira, et al.
Publicado: (2020)

Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
por: Perretta-Tejedor, Nuria, et al.
Publicado: (2017)

Druggable Drivers of Lung Cancer
por: Fawdar, Shameem, et al.
Publicado: (2013)

Corrigendum: Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
por: Perretta-Tejedor, Nuria, et al.
Publicado: (2018)

Prognostic Factors for Adrenocortical Carcinoma Outcomes
por: Scollo, Claudia, et al.
Publicado: (2016)

Complex and pleiotropic signaling pathways regulated by the secreted protein augurin
por: Richter, Margaux, et al.
Publicado: (2023)

FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
por: Tamburello, Mariangela, et al.
Publicado: (2022)

Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets
por: Souza, Rhonda F.
Publicado: (2018)

VAV2 and VAV3 as Candidate Disease Genes for Spontaneous Glaucoma in Mice and Humans
por: Fujikawa, Keiko, et al.
Publicado: (2010)

Low Protein Expression of both ATRX and ZNRF3 as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma
por: Brondani, Vania Balderrama, et al.
Publicado: (2021)

KIF11 is a potential prognostic biomarker and therapeutic target for adrenocortical carcinoma
por: Zhou, Yan, et al.
Publicado: (2023)

SAT274 Multilocus Imprinting Disorder Due To Genome-wide Paternal Uniparental Disomy Associated With Adrenocortical Tumors
por: Pinto, Emilia Modolo, et al.
Publicado: (2023)

Novel Biomarkers and Druggable Targets in Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021)

SAT-165 Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma
por: Lacombe, Amanda Meneses Ferreira, et al.
Publicado: (2020)

Nicotinamide Nucleotide Transhydrogenase as a Novel Treatment Target in Adrenocortical Carcinoma
por: Chortis, Vasileios, et al.
Publicado: (2018)

Ampullary carcinoma prognostic markers
por: Perkins, Geraldine, et al.
Publicado: (2019)

Prognostic Role of Targeted Methylation Analysis in Paraffin-embedded Samples of Adrenocortical Carcinoma
por: Lippert, Juliane, et al.
Publicado: (2022)

Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
por: Cantini, Giulia, et al.
Publicado: (2021)

Sequence-Derived Markers of Drug Targets and Potentially Druggable Human Proteins
por: Ghadermarzi, Sina, et al.
Publicado: (2019)

Vav2 is required for cell spreading
por: Marignani, Paola A., et al.
Publicado: (2001)

The prognostic value and immunological role of SULF2 in adrenocortical carcinoma
por: Yan, Jiusong, et al.
Publicado: (2023)

Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
por: Liang, Weiwei, et al.
Publicado: (2021)

Clinical and Histopathological Variables and Prognostic Factors of Adrenocortical Carcinoma
por: Sohail, Sara, et al.
Publicado: (2021)

The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets
por: Hassan, Syed S., et al.
Publicado: (2018)

The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function
por: Lorenzo-Martín, L. Francisco, et al.
Publicado: (2022)

A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence
por: Surakhy, Mirvat, et al.
Publicado: (2020)

Prognostic marker and target in prostate cancer
por: Lavorgna, Giovanni, et al.
Publicado: (2015)

Targeted Therapies and Druggable Genetic Anomalies in Acute Myeloid Leukemia: From Diagnostic Tools to Therapeutic Interventions
por: Lanza, Francesco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f9jtikmpi771rahr0omeh3ld6u